Cutaneous cytokine expression: Induction by chemical allergen and paracrine regulation

Journal of Toxicology - Cutaneous and Ocular Toxicology

Volumn 22, Issue 1-2, 2003, Pages 69-86

  Dearman, Rebecca J ^a   Cumberbatch, Marie ^a   Kimber, Ian ^a  

^a JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

Author keywords

Chemical allergen; Interleukin 1 ; Interleukin 6; Langerhans cells; Tumor necrosis factor

Indexed keywords

ALLERGEN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; CYTOKINE PRODUCTION; EPIDERMIS; IMMUNE RESPONSE; KINETICS; LANGERHANS CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UPREGULATION;

ANIMALIA; MURINAE;

EID: 0038407606     PISSN: 07313829     EISSN: None     Source Type: Journal    
DOI: 10.1081/CUS-120020313     Document Type: Article

References (40)

1. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 1992; 89:1398-1402.
2. Takashima A, Bergstresser PR. Impact of UVB irradiation on the epidermal cytokine network. Photochem Photobiol 1996; 63:397-400.
3. Sebastiani S, Albanesi C, De PO, Puddu P, Cavani A, Girolomoni G. The role of chemokines in allergic contact dermatitis. Arch Dermatol Res 2002; 293:552-559.
4. Kimber I, Cumberbatch M, Dearman RJ, Bhushan M, Griffiths CEM. Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br J Dermatol 2000; 142:401-412.
5. Kripke ML, Munn CG, Jeevan A, Tang J-M, Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990; 145:2833-2838.
6. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J Exp Med 1987; 166:1654-1667.
7. Kimber I, Cumberbatch M, Dearman RJ, Knight SC. Langerhans cell migration and cellular interactions. In: Lotze MT, Thomson AW, eds. Dendritic Cells, Biology and Clinical Applications. San Diego: Academic Press, 1999; 295-310.
8. Kimber I, Dearman RJ. Investigation of lymph node cell proliferation as a possible immunological correlate of contact sensitizing potential. Food Chem Toxicol 1991; 29:125-129.
9. Heufler C, Koch F, Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 1988; 167:700-705.
10. Mizutani H, Black R, Kupper TS. Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies pf IL-1 production and processing in monocytes and keratinocytes. J Clin Investig 1991; 87:1066-1071.
11. Cumberbatch M, Kimber I. Dermal TNF-α induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans cell migration. Immunology 1992; 75:257-263.
12. Cumberbatch M, Fielding I, Kimber I. Modulation of epidermal Langerhans cell frequency by TNF-α. Immunology 1994; 81:395-401.
13. Cumberbatch M, Dearman RJ, Kimber I. Langerhans cells require signals from both tumour necrosis factor-α and interleukin-1β for migration. Immunology 1997; 92:305-388.
14. Cumberbatch M, Dearman RJ, Kimber I. Interleukin-1β for and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor-α. Arch Dermatol Res 1997; 289:277-284.
15. Cumberbatch M, Kimber I. Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 1995; 84:31-35.
16. Shomick LP, De Togni P, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Ferguson TA, Chaplin DD. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzene. J Exp Med 1996; 183:1427-1436.
17. Antonopoulos C, Cumberbatch M, Dearman RJ, Daniel RJ, Kimber I, Groves RW. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J Immunol 2001; 166:3672-3677.
18. Enk AH, Angeloni VL, Udey M, Katz SI. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in the skin. J Immunol 1993; 150:3698-3704.
19. Cumberbatch M, Dearman RJ, Kimber I. Inhibition by dexamethasone of Langerhans cell migration: influence of epidermal cytokine signals. Immunopharmacology 1999; 41:235-241.
20. Kermani F, Flint MS, Hotchkiss SAM. Induction and localization of cutaneous interleukin-1β mRNA during contact sensitization. Toxicol Appl Pharmacol 2000; 169:231-237.
21. Holliday MR, Dearman RJ, Corsini E, Basketter DA, Kimber I. Selective stimulation of cutaneous interleukin 6 expression by skin allergens. J Appl Toxicol 1996; 16:65-70.
22. Holliday MR, Corsini E, Smith S, Basketter DA, Dearman RJ, Kimber I. Differential induction of cutaneous TNF-α and IL-6 by topically applied chemicals. Am J Contact Dermatitis 1997; 8:158-164.
23. Holliday MR, Dearman RJ, Basketter DA, Kimber I. Stimulation by oxazolone of increased IL-6, but not IL-10, in the skin of mice. Toxicology 1996; 106:237-242.
24. Mosley B, Urdal DL, Prickett KS, Larsen A, Cosmann D, Conlon PJ, Gillis S, Dower SK. The interleukin 1 receptor binds the human interleukin-1α precursor but not the interleukin-1β precursor. J Biol Chem 1987; 262:2941-2944.
25. Dinarello CA. Biologic basis for interleukin 1 in disease. Blood 1987; 87:2095-2147.
26. Rosenwasser LJ. Biologic activities of IL-1 and its role in human disease. J Allergy Clin Immunol 1998; 102:344-350.
27. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, Miller DK, Molineaux SM, Weidner JR, Aunins J, Schmidt JA, Tocci M. A novel hetereodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356:768-774.
28. Wilson KP, Black JA, Thomson JA, Kim EE, Griffith JP, Navia MA, Mureko MA, Chambers SP, Aldape RA, Raybuck SA, Livingston DJ. Structure and mechanism of interleukin-1β converting enzyme. Nature 1994; 370:270-275.
29. Ariizumi K, Kitajima T, Bergstresser PR, Takashima A. Interleukin-1β converting enzyme in murine Langerhans cells and epidermal-derived dendritic cells. Eur J Immunol 1995; 25:2137-2141.
30. Dearman RJ, Caddick H, Basketter DA, Kimber I. Divergent antibody isotype responses induced in mice by systemic exposure to proteins: a comparison of ovalbumin with bovine serum albumin. Food Chem Toxicol 2000; 38:351-360.
31. Schreiber S, Kilgus O, Payer E, Kutil R, Elbe A, Mueller C, Stingl G. Cytokine patterns of Langerhans cells isolated from murine epidermal cell cultures. J Immunol 1994; 149:3525-3534.
32. Cumberbatch M, Dearman RJ, Kimber I. Constitutive and inducible expression of interleukin-6 by Langerhans cells and lymph node dendritic cells. Immunology 1996; 87:513-518.
33. Kirnbauer R, Kak A, Schwartz T, Urbanski A, Krutmann J, Borth W, Damm D, Shigley G, Ansel JC, Luger T. IFN-β2 cell differentiation factor 2, or hybridoma growth factor (IL6) is expressed and released by epidermal cells and epidermoid carcinoma cell lines. J Immunol 1992; 148:1922-1928.
34. Kimber I, Cumberbatch M, Humphreys M, Hopkins SJ. Contact hypersensitivity induces plasma interleukin 6. Int Arch Allergy Appl Immunol 1990; 92:97-99.
35. Le J, Vilcek J. Interleukin 6: a multifunctional cytokine regulating immune reaction and the acute phase protein response. Lab Investig 1992; 61:588-602.
36. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990; 8:253-278.
37. Hope JC, Dearman RJ, Debicki RJ, Kimber I, Hopkins SJ. Interleukin-6 production by draining lymph node cells following primary contact sensitisation of mice: relationship to the proliferative response. Int Arch Allergy Immunol 1994; 103:378-383.
38. Lee CE, Neuland ME, Teaford HG, Villacis BF, Dixon PS, Valtier S, Yeh C-H, Fournier DC, Charlesworth EN. Interleukin-6 is released in the cutaneous response to allergen challenge in atopic individuals. J Allergy Clin Immunol 1992; 89:1010-1020.
39. Griffiths CEM, Cumberbatch M, Tucker SC, Dearman RJ, Andrew S, Headon DR, Kimber I. Exogenous topical lactoferrin inhibits allergen-induced Langerhans cell migration and cutaneous inflammation in humans. Br J Dermatol 2001; 144:715-725.
40. Cumberbatch M, Bhushan M, Dearman RJ, Griffiths CEM, Kimber I. Lactoferrin inhibits interleukin 1β-induced Langerhans cell migration and epidermal tumour necrosis factor-α production in humans. Br J Dermatol 2002; 146:729 (Abstract).